Montai Therapeutics is pioneering at the intersection of technology, validated biology, and diverse, untapped human chemistry in pursuit of transformative medicines for chronic disease. Montai’s CONECTA platform enables the predictable discovery of efficacious small molecules that can precisely engage complex biologic targets and pathways and have the potential to become medicines for long-term use and earlier intervention.